Indian Overseas Bank and Central Bank of India will benefit from the government's recent capital infusion as they have got a higher share as a proportion of their share capital, Moody's said today. "The capital infusion will improve their capitalisation at a time when asset quality pressure and elevated provisioning costs have negatively affected their financial performance," it said in its credit outlook titled, 'Indian Overseas Bank and Central Bank of India benefit from Government's capital infusion'. Last week, the government announced a Rs 22,915 crore capital infusion into 13 PSBs. Of this, IOB received Rs 3,101 crore and Central Bank got Rs 1,729 crore. The capital infusion is positive for weaker banks such as the Indian Overseas Bank (IOB) and Central Bank of India, which received a higher share of the capital allocation as a proportion of their share capital, Moody's said. Shares of Central Bank jumped 3.08 per cent to Rs 100.55, while IOB gained 0.18 per cent to Rs 27.20 on BSE today. Indian banks continue to recognise non-performing loans (NPLs) from larger leveraged corporates, especially in the steel and power sectors, pressurizing their asset quality. Also, slippages from the restructured loan book will contribute to the rise in NPLs. "As a result, provisioning expenses are likely to remain elevated, constraining profitability and limiting the banks internal capital generation. In this context, the capital infusion will provide some respite to the recipient banks, especially those with weak capitalisation," Moody's said. Currently, such banks have market valuations significantly below book value, and are challenged to raise capital from public markets, it said. Hence, they have a greater dependence on government infusions for capital support. This timely round of capital infusion augments their capitalization, aiming to improve their ability to raise equity capital from public markets, Moody's added. The government had last year announced it will infuse Rs 70,000 crore into the state run banks over four years while they will have to raise a further Rs 1.1 lakh crore from the markets to meet their capital requirements in line with global risk norms Basel-III. In line with the blueprint, PSU banks are to get Rs 25,000 crore each in 2015-16 and 2016-17 fiscals. Besides, Rs 10,000 crore each would be infused in 2017-18 and 2018-19.
Monday, 25 July 2016
Home »
» IOB, Central Bank to benefit from capital infusion -:- Equity Research
IOB, Central Bank to benefit from capital infusion -:- Equity Research
04:16
Related Posts:
Govt working on rollout of GST from next April-:- Equity Research Government is working on a target date of April 1, 2017 for the rollout of Goods and Services Tax, and the first meeting of the GST Council was held in a "very cordial and constructive environment", Finance Minister Arun J… Read More
Only Parliament can form Cauvery Water Mgmt Board-:- Equity Research The Centre has told the Supreme Court that forming the Cauvery Water Management Board is the sole prerogative of Parliament and that the court can’t order the government on this. The Attorney General Mukul Rohatgi informe… Read More
L&T bags orders worth Rs 6,024 crore-:- Equity Research Infrastructure major Larsen and Toubro (L&T) has bagged orders worth Rs 6,024 crore across various business segments. "The construction arm of L&T has won orders worth Rs 6,024 crore across various business segment… Read More
NSE's share grows in equity, equity derivatives in HI FY'17-:- Equity Research In a sign of growing investor interest in equity and equity derivatives, NSE today said its market share has surged in these segments in April-September 2016 period, mainly on account of awareness programs organised by the… Read More
RBI shifts monetary policy timing to mid-afternoon-:- Equity Research The Reserve Bank has decided to change the timing of announcement of its policy review, due next Tuesday, to mid-afternoon. For long, the central bank has been unveiling the monetary policy at 11 am. "The resolutio… Read More
0 comments:
Post a Comment